Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Incidence is increasing for six of 12 obesity-related cancers, including colorectal, kidney and pancreatic.
Less than 5 percent of Black patients were involved in trials for 24 out of 31 cancer drugs approved since 2015.
With the exception of colon cancer, most cancers associated with overweight or obesity rose over the past decade.
Trials of immunotherapy drug for multiple myeloma suspended after patient deaths.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.